Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06461962

Rural Community Peer Partnerships for Improving Methamphetamine-Associated Heart Failure Screening and Engagement

The goal of PEER-Heart is to implement and assess feasibility and preliminary effectiveness of a community peer-facilitated screening for methamphetamine-associated heart failure (MAHF) and linkage to evidence-based cardiology care for people who use methamphetamine in rural areas.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Oregon Health & Science University

Portland, Oregon, 97239, United States

Location status: Recruiting

Location contact

Brian Chan, MD, MPH

CONTACT

[email protected]

503-494-2010

About this study

Methamphetamine use has increased across the US in the midst of the opioid crisis, with rates of methamphetamine use in rural communities exceeding that in urban areas. Nationwide, methamphetamine-related hospitalizations increased 270% between 2007 and 2015, along with associated costs, lengths of stay and mortality. Methamphetamine-associated heart failure (MAHF) hospitalizations increased 12-fold over this time period; it is associated with worse symptoms (e.g. ejection fraction) and decreased adherence to guideline-directed medical therapy (GDMT) compared to heart failure not associated with methamphetamine use.

Despite the increased risk of heart failure and overdose for people who use methamphetamine in rural areas, interventions to improve engagement in cardiac screening and treatment services are underdeveloped. Multiple barriers decrease access to cardiac care in rural communities, including social determinants of health and health systems care delivery barriers. Stigma and distrust of healthcare providers, particularly in rural communities are known barriers to engaging in medical care-COVID-19 has only worsened this gap for people who use drugs.

Team-based cardiology care interventions can improve outcomes for people with heart failure, including one multi-disciplinary program that focused on methamphetamine-associated heart failure MAHF. However, these interventions have been tested in urban, higher resourced settings than those typical in rural communities. Interventions for screening and linkage to care for people who use drugs in rural areas with MAHF have not been developed.

The "experiential credentialing" afforded by peer recovery support specialists ("peers") offers a unique opportunity to reach, engage, and retain non-treatment-seeking people using drugs. The PEER-Heart study extends the role of peers as trusted community health workers in rural communities to improve MAHF screening and linkage to cardiology care. Increasing evidence reports feasibility, acceptability, and effectiveness of telehealth interventions in rural communities including cardiology services and retention in substance use treatment. Virtual visits for heart failure demonstrate promise in improving follow-up care though more study is warranted to demonstrate clinical outcomes effectiveness, and ensure these interventions do not worsen existing health inequities and the rural digital divide, particularly in minoritized groups.

The PEER-Heart study aims to demonstrate feasibility of screening of MAHF and linkage to evidence-based cardiology care for people who use methamphetamine in rural areas.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patient-defined regular use of methamphetamine in the last year
  • Any methamphetamine use in the past 30 days
  • Age 18 years or older
  • No client-reported diagnosis of heart failure
  • Able to communicate in English
  • Screen positive for potential methamphetamine-associated heart failure (MAHF) defined as B type natriuretic peptide (BNP) ≥50 pg/ml, or QRS width ≥120ms, or presence of any clinical heart failure symptoms

Exclusion criteria

  • Self-reported engagement in medical care for heart failure in past 6 months.
  • Actively taking medications for heart failure.

Treatment and study plan

Treatment as Usual

Other

Peer-facilitated referral to a local primary care provider to follow-up their screening results.

Telehealth-Cardiology

Other

Peer-facilitated virtual consultation with cardiovascular specialist, for follow-up of their screening results. Activities may include: referral for a locally performed testing including echocardiogram and additional blood work, and transitional care management facilitated by a remote nurse care manager and the peer

Referral for a locally performed testing including echocardiogram

Transitional care management facilitated by a remote nurse care manager and the peer

Primary outcomes

  1. Linkage to cardiology care

    Time frame: 2 months

    Proportion of participants who are engaged in cardiac care at 2 months after screening.

Secondary outcomes

  1. Linkage to diagnostic echocardiogram

    Time frame: 2 months

    Proportion of participants who complete a diagnostic echocardiogram within 2 months after randomization.

  2. Goal Directed Medical Therapy (GDMT) prescribed

    Time frame: 6 months

    Proportion of eligible patients who are on any GDMT at 6 months after randomization

Study contacts

Contact information is provided by the study sponsor or research team.

Brian Chan, MD, MPH

CONTACT

[email protected]

503-494-2010

Kellie Pertl, MPH

CONTACT

[email protected]

Sponsors and collaborators

Lead sponsor

Oregon Health and Science University

Other

Collaborators

  • Bay Area First Step
  • University of Washington

Registry information

Acronym: PEER-Heart

Important dates

Study start
2024
Primary completion
2029
Study completion
2029
First posted
Jun 17, 2024
Registry last updated
Mar 21, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.